-

Global Medical Custom Procedure Kits Markets, 2021-2022 & 2028 - Advanced Logistics & Supply Chain and Innovative Practices by Manufacturers Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Custom Procedure Kits Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Procedure and Type" report has been added to ResearchAndMarkets.com's offering.

Custom Procedure Kits Market for Orthopedic Segment to Grow Significantly During 2021-2028

The market is projected to reach US$ 13,816.53 million by 2028 from US$ 6,970.97 million in 2021; it is estimated to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing the growth of the market.

The customized procedure kits contain all the medical equipment needed for a specific surgical procedure. It replaces many individual packages and saves time and money in minor and extensive surgical procedures. Also, the preparation time for surgical procedures can be reduced by half compared to the traditional preparation of the operating room.

There are several benefits of custom treatment packages, such as reducing emergency surgery response time, reducing ordering and administrative costs, reducing clinical waste, providing access to various drape manufacturers, eliminating errors, and addressing surgeon preferences.

Physician specified kit formula range is developed and assembled in a certified cleanroom environment. They are designed to meet the demanding process requirements of any core specialist. Today, medical manufacturers receive commissions from healthcare institutions to design and assemble specialized kits for all types of medical emergencies.

The manufacturer is always looking for support from the medical community on putting together an individual procedure kit more efficiently and cost-effectively. Through the healthcare community's efforts and healthcare product manufacturers, they can provide doctors and nurses with suitable procedure kits at the right time. Individual and specialized instruments are included in custom procedure kits to expedite patient care.

Increase in number of surgeries globally coupled with growing preference of healthcare providers towards procedure specific packs and increase in geriatric population are some of the factors that help to drive the custom procedure kits market growth. However, the lack of standardization among the practitioners that utilize kits hamper the custom procedure kits market growth.

Based on procedure, the custom procedure kits market is further segmented into bariatric, colorectal, thoracic, orthopedic, ophthalmology, spine surgery, cardiac surgery, and others. The orthopedic segment would lead the market in 2021 with a share of 44.86% and is expected to retain its dominance during the forecast period, thereby accounting for 44.39% of the total market by 2028.

The growth of this segment is attributed to the rising joint replacement surgeries and the growing popularity of custom procedure kits among healthcare professionals. Moreover, benefits of customization, such as reduction in the time of stepping the equipment during surgery will further supplement the custom procedure kits market growth.

Medline Industries, Inc.; Teleflex Incorporated; Owens & Minor Inc.; Medtronic; Cardinal Health Inc; McKESSON CORPORATION; Smiths Medical; Terumo Cardiovascular Systems Corporation; CPT Medical; and OneMed are among the leading companies operating in the custom procedure kits market.

Key Market Dynamics

Market Drivers

  • Increasing Geriatric Population Susceptible to Chronic Diseases Requiring Surgery
  • Rising Cosmetic Surgeries and Other Surgeries (General Surgery, Orthopaedic, and Urology)

Market Restraints

  • Demand & Supply Gap and Lack of Standardization

Market Opportunities

  • Innovative Practices by Manufacturers

Future Trends

  • Advanced Logistics & Supply Chain

Company Profiles

  • Medline Industries, Inc.
  • Teleflex Incorporated
  • Owens & Minor Inc.
  • Medtronic
  • Cardinal Health Inc
  • Mckesson Corporation
  • Smiths Medical
  • Terum- Cardiovascular Systems Corporation
  • Cpt Medical
  • Onemed

For more information about this report visit https://www.researchandmarkets.com/r/e3sobd

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Trends Shaping the $5 Billion Spasticity Treatment Market, 2026-2034: Focus on Multimodal Care and Treatment Innovations - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spasticity Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The global Spasticity Treatment Market, valued at USD 5.02 billion in 2025, is set to expand at a CAGR of 5.5%, reaching USD 8.13 billion by 2034. This growth is driven by innovations in pharmacologic therapies, interventional procedures, and multimodal rehabilitative modalities designed to manage spasticity associated with various...

Intracranial Aneurysm Market and Competition Outlook 2026-2034: Market Share, Growth Analysis, Strategic Initiatives and Emerging Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intracranial Aneurysm Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Intracranial Aneurysm Market, valued at USD 1.79 billion in 2025, is forecasted to grow at a CAGR of 10% to reach USD 4.22 billion by 2034. Trends indicate enhanced demand for low-profile flow diverters, resheathable delivery systems, and AI-assisted aneurysm detection, propelled by the global incidence of subarachnoid hemorrha...

Insomnia Drugs Market Outlook 2026-2034: Trends, Shares, and Growth Analysis Featuring Merck & Co., Eisai Co., Viatris, Perrigo Co., Neurim Pharmaceuticals and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Insomnia Drug Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Insomnia Drug Market is projected to expand from USD 2.95 billion in 2025 to USD 4.62 billion by 2034, exhibiting a CAGR of 5.1%. Encompassing both prescription and OTC solutions, the market spans across various formulations designed to alleviate sleep-onset and sleep-maintenance issues. Key pharmacologic categories include non-benzodi...
Back to Newsroom